Simon Amy sold BEAM
June 30, 2026 · Form 4 insider transaction
Simon Amy sold 373 shares of Beam Therapeutics Inc. at $34.73 per share, a transaction worth $13.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
373
Price
$34.73
Total value
$13.0K
InsiderSimon Amy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after102,363
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on June 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.